Nov 25 (Reuters) - Isofol Medical AB (publ):
* FINAL DATA FROM THE AGENT STUDY CONFIRMS TOPLINE RESULTS
* ANALYSIS OF AGENT STUDY'S FINAL DATA CONFIRMED TOPLINE RESULTS PRESENTED ON AUGUST 3, 2022
* ISOFOL IS IN PARALLEL CONTINUING TO INVESTIGATE POSSIBLE FUTURE PATHS FORWARD FOR COMPANY Source text for Eikon: Further company coverage: (Gdansk Newsroom)